<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40450331</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1475-2891</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>Nutrition journal</Title><ISOAbbreviation>Nutr J</ISOAbbreviation></Journal><ArticleTitle>Optimizing serum 25(OH)D levels to mitigate the risk of age-related ocular diseases: insights from a large-scale prospective cohort study.</ArticleTitle><Pagination><StartPage>88</StartPage><MedlinePgn>88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12937-025-01156-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Investigations into the association between serum 25-hydroxyvitamin D (25(OH)D) levels and the risk of age-related ocular diseases have yielded inconsistent results. Thus, we aimed to provide robust longitudinal evidence, identify optimal serum thresholds, and explore the underlying mechanisms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed data of 322,953 participants from the UK Biobank. The serum 25(OH)D levels were assessed using chemiluminescent immunoassay. Outcomes were incidences of cataract, primary open-angle glaucoma (POAG), age-related macular degeneration (AMD), and diabetic retinopathy (DR). Hazard ratios and 95% confidence intervals were estimated using Cox proportional hazards models. Nonlinear relationships were explored using restricted cubic splines, and mediation analyses were performed to delineate potential mechanistic pathways.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our findings revealed U-shaped associations for cataract and AMD, and L-shaped associations for DR (all P&#x2009;&lt;&#x2009;0.05), with an optimal threshold of approximately 50 nmol/L, while no association with POAG was observed. Below this threshold, each 10 nmol/L increase in serum 25(OH)D concentration was linked to a 3.5%, 4.2%, and 6.0% reduction in the risk of cataract, AMD, and DR, respectively (HR 0.965 [95% CI 0.951-0.980]; HR 0.958 [95% CI 0.921-0.997]; HR 0.940 [95% CI 0.894-0.989], respectively), while above 50 nmol/L, no significant protective effects were observed. Mediation analyses revealed that the low-grade inflammation score and triglyceride-glucose index may mediate the effects of serum 25(OH)D on cataract and DR.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study identified 50 nmol/L as the optimal serum 25(OH)D threshold for reducing risks of cataract, AMD and DR, with no benefits beyond this level. The protective effects may be mediated through modulation of inflammation and glucolipid metabolism pathways. The threshold effects highlight the importance of targeted vitamin D supplementation under careful monitoring of serum levels to optimize ocular health outcomes.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Zhiqian</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Eye Institute, Department of Ophthalmology, Eye &amp; ENT Hospital, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Shuyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Eye Institute, Department of Ophthalmology, Eye &amp; ENT Hospital, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Eye Institute, Department of Ophthalmology, Eye &amp; ENT Hospital, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Keke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Eye Institute, Department of Ophthalmology, Eye &amp; ENT Hospital, Fudan University, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, 200031, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Eye Institute, Department of Ophthalmology, Eye &amp; ENT Hospital, Fudan University, Shanghai, 200031, China. joycedu624@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China. joycedu624@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, 200031, China. joycedu624@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China. joycedu624@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xiangjia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Eye Institute, Department of Ophthalmology, Eye &amp; ENT Hospital, Fudan University, Shanghai, 200031, China. zhuxiangjia1982@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Myopia and Related Eye Diseases, Key Laboratory of Myopia and Related Eye Diseases, Chinese Academy of Medical Sciences, Shanghai, 200031, China. zhuxiangjia1982@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Myopia, Chinese Academy of Medical Science, Shanghai, 200031, China. zhuxiangjia1982@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, 200031, China. zhuxiangjia1982@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82122017, 82271069, 81870642, 82371040, 81970780, 81470613, 81670835 and 82201161</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>23Y11909800 and 21S31904900</GrantID><Agency>Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission</Agency><Country/></Grant><Grant><GrantID>SHDC12020111</GrantID><Agency>Clinical Research Plan of Shanghai Shenkang Hospital Development Center</Agency><Country/></Grant><Grant><GrantID>shslczdzk01901</GrantID><Agency>Shanghai Municipal Key Clinical Specialty Program</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nutr J</MedlineTA><NlmUniqueID>101152213</NlmUniqueID><ISSNLinking>1475-2891</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age-related ocular disease</Keyword><Keyword MajorTopicYN="N">Inflammatory status</Keyword><Keyword MajorTopicYN="N">Nonlinear association</Keyword><Keyword MajorTopicYN="N">Serum 25(OH)D</Keyword><Keyword MajorTopicYN="N">TyG index</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval: The UK Biobank is being conducted according to the guidelines of the Declaration of Helsinki and was approved by the North West Haydock Research Ethics Committee (#16/NW/0274, 13 May 2016). UK Biobank obtained informed consent from all individual participants included in the study during the recruitment process. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>1</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40450331</ArticleId><ArticleId IdType="doi">10.1186/s12937-025-01156-y</ArticleId><ArticleId IdType="pii">10.1186/s12937-025-01156-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collaborators GBVI. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health Feb. 2021;9(2):e144&#x2013;60. https://doi.org/10.1016/s2214-109x(20)30489-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2214-109x(20)30489-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends in prevalence of. Blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet Glob Health Feb. 2021;9(2):e130&#x2013;43. https://doi.org/10.1016/s2214-109x(20)30425-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2214-109x(20)30425-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Li R, Zhang Y, et al. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis. Lancet Glob Health Mar. 2023;11(3):e456&#x2013;65. https://doi.org/10.1016/s2214-109x(22)00554-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2214-109x(22)00554-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Seddon JM. Genetic and environmental underpinnings to age-related ocular diseases. Invest Ophthalmol Vis Sci Dec. 2013;13(14):Orsf28&#x2013;30. https://doi.org/10.1167/iovs.13-13234 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.13-13234</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez VL, Caspi RR. Immune mechanisms in inflammatory and degenerative eye disease. Trends Immunol Jun. 2015;36(6):354&#x2013;63. https://doi.org/10.1016/j.it.2015.04.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2015.04.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergroesen JE, Thee EF, de Crom TOE, et al. The inflammatory potential of diet is associated with the risk of age-related eye diseases. Clin Nutr Dec. 2023;42(12):2404&#x2013;13. https://doi.org/10.1016/j.clnu.2023.10.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2023.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinari C, Rizzi M, Squarzanti DF, Pittarella P, Vacca G, Ren&#xf2; F. 1&#x3b1;,25-Dihydroxycholecalciferol (Vitamin D3) induces NO-dependent endothelial cell proliferation and migration in a three-dimensional matrix. Cell Physiol Biochem. 2013;31(6):815&#x2013;22. https://doi.org/10.1159/000350099 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000350099</ArticleId><ArticleId IdType="pubmed">23816836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha A, Hollingsworth KG, Ball S, Cheetham T. Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab Mar. 2013;98(3):E509&#x2013;13. https://doi.org/10.1210/jc.2012-3592 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2012-3592</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez M, Recalde S, Gonz&#xe1;lez-Zamora J, et al. Anti-Inflammatory and Anti-Oxidative synergistic effect of vitamin D and nutritional complex on retinal pigment epithelial and endothelial cell lines against Age-Related macular degeneration. Nutrients Apr. 2021;23(5). https://doi.org/10.3390/nu13051423 .</Citation></Reference><Reference><Citation>Tohari AM, Almarhoun M, Alhasani RH, et al. Protection by vitamin D against high-glucose-induced damage in retinal pigment epithelial cells. Exp Cell Res Jul. 2020;1(1):112023. https://doi.org/10.1016/j.yexcr.2020.112023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Lu Q, Chen W, Li J, Li C, Zheng Z. Vitamin D(3) protects against diabetic retinopathy by inhibiting High-Glucose-Induced activation of the ROS/TXNIP/NLRP3 inflammasome pathway. J Diabetes Res. 2018;2018:8193523. https://doi.org/10.1155/2018/8193523 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8193523</ArticleId><ArticleId IdType="pubmed">29682582</ArticleId><ArticleId IdType="pmc">5842685</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord Jun. 2017;18(2):153&#x2013;65. https://doi.org/10.1007/s11154-017-9424-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-017-9424-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman KD, Dowling KG, &#x160;krab&#xe1;kov&#xe1; Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr Apr. 2016;103(4):1033&#x2013;44. https://doi.org/10.3945/ajcn.115.120873 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.115.120873</ArticleId></ArticleIdList></Reference><Reference><Citation>Meshkin A, Badiee F, Salari N, Hassanabadi M, Khaleghi AA, Mohammadi M. The global prevalence of vitamin D deficiency in the elderly: A Meta-analysis. Indian J Orthop Mar. 2024;58(3):223&#x2013;30. https://doi.org/10.1007/s43465-023-01089-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43465-023-01089-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev Aug. 2019;1(4):1109&#x2013;51. https://doi.org/10.1210/er.2018-00126 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2018-00126</ArticleId></ArticleIdList></Reference><Reference><Citation>Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol Dec. 2017;5(12):986&#x2013;1004. https://doi.org/10.1016/s2213-8587(17)30357-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-8587(17)30357-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan Z, Guo J, Pan A, Chen C, Liu L, Liu G. Association of serum 25-Hydroxyvitamin D concentrations with All-Cause and Cause-Specific mortality among individuals with diabetes. Diabetes Care Feb. 2021;44(2):350&#x2013;7. https://doi.org/10.2337/dc20-1485 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1485</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X, Wang J, Song M, et al. Vitamin D status and risk of All-Cause and Cause-Specific mortality in a large cohort: results from the UK biobank. J Clin Endocrinol Metab Oct. 2020;1(10). https://doi.org/10.1210/clinem/dgaa432 .</Citation></Reference><Reference><Citation>Park S, Choi NK. Serum 25-hydroxyvitamin D and Age-Related cataract. Ophthalmic Epidemiol Oct. 2017;24(5):281&#x2013;6. https://doi.org/10.1080/09286586.2017.1281427 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09286586.2017.1281427</ArticleId></ArticleIdList></Reference><Reference><Citation>Jee D, Kim EC. Association between serum 25-hydroxyvitamin D levels and age-related cataracts. J Cataract Refract Surg Aug. 2015;41(8):1705&#x2013;15. https://doi.org/10.1016/j.jcrs.2014.12.052 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrs.2014.12.052</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdellah MM, Mohamed Mostafa E, Salama EH, Roshdy Mohamed E. Association of serum 25-Hydroxyl vitamin D deficiency and Age-Related cataract: A Case-Control study. J Ophthalmol. 2019;2019:9312929. https://doi.org/10.1155/2019/9312929 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9312929</ArticleId><ArticleId IdType="pubmed">31143475</ArticleId><ArticleId IdType="pmc">6501145</ArticleId></ArticleIdList></Reference><Reference><Citation>Graffe A, Milea D, Annweiler C, et al. Association between hypovitaminosis D and late stages of age-related macular degeneration: a case-control study. J Am Geriatr Soc Jul. 2012;60(7):1367&#x2013;9. https://doi.org/10.1111/j.1532-5415.2012.04015.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2012.04015.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim EC, Han K, Jee D. Inverse relationship between high blood 25-hydroxyvitamin D and late stage of age-related macular degeneration in a representative Korean population. Invest Ophthalmol Vis Sci Jul. 2014;11(8):4823&#x2013;31. https://doi.org/10.1167/iovs.14-14763 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.14-14763</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez Serena A, Mart&#xed;nez Betancourt DP, Del Gonz&#xe1;lez F, Ruiz-Moreno JM. Serum 25-hydroxy vitamin D levels in age-related macular degeneration. Int J Retina Vitreous Mar. 2022;7(1):17. https://doi.org/10.1186/s40942-022-00368-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40942-022-00368-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Krefting EA, Jorde R, Christoffersen T, Grimnes G. Vitamin D and intraocular pressure&#x2013;results from a case-control and an intervention study. Acta Ophthalmol Jun. 2014;92(4):345&#x2013;9. https://doi.org/10.1111/aos.12125 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.12125</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo TK, Oh E, Hong S. Is vitamin D status associated with open-angle glaucoma? A cross-sectional study from South Korea. Public Health Nutr Apr. 2014;17(4):833&#x2013;43. https://doi.org/10.1017/s1368980013003492 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s1368980013003492</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves A, Milea D, Gohier P, et al. Serum vitamin D status is associated with the presence but not the severity of primary open angle glaucoma. Maturitas Aug. 2015;81(4):470&#x2013;4. https://doi.org/10.1016/j.maturitas.2015.05.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2015.05.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Kwon YJ, Lee HS, Han JH, Joung B, Kim SJ. Inverse relationship between serum 25-Hydroxyvitamin D and elevated intraocular pressure. Nutrients Jan. 2023;13(2). https://doi.org/10.3390/nu15020423 .</Citation></Reference><Reference><Citation>Shimo N, Yasuda T, Kaneto H, et al. Vitamin D deficiency is significantly associated with retinopathy in young Japanese type 1 diabetic patients. Diabetes Res Clin Pract Nov. 2014;106(2):e41&#x2013;3. https://doi.org/10.1016/j.diabres.2014.08.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2014.08.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Ot&#xed; JM, Galv&#xe1;n-Manso AI, Callejas-Herrero MR, Vara-Gonz&#xe1;lez LA, Salas-Herrera F, Mu&#xf1;oz-Cacho P. Vitamin D deficiency is significantly associated with retinopathy in type 2 diabetes mellitus: A Case-Control study. Nutrients Dec. 2021;25(1). https://doi.org/10.3390/nu14010084 .</Citation></Reference><Reference><Citation>Luo BA, Gao F, Qin LL. The association between vitamin D deficiency and diabetic retinopathy in type 2 diabetes: A Meta-Analysis of observational studies. Nutrients Mar. 2017;20(3). https://doi.org/10.3390/nu9030307 .</Citation></Reference><Reference><Citation>Rahman ST, Waterhouse M, Romero BD, et al. Vitamin D supplementation and the incidence of cataract surgery in older Australian adults. Ophthalmology Mar. 2023;130(3):313&#x2013;23. https://doi.org/10.1016/j.ophtha.2022.09.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2022.09.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Christen WG, Cook NR, Manson JE, et al. Effect of vitamin D and &#x3c9;-3 fatty acid supplementation on risk of Age-Related macular degeneration: an ancillary study of the VITAL randomized clinical trial. JAMA Ophthalmol Dec. 2020;1(12):1280&#x2013;9. https://doi.org/10.1001/jamaophthalmol.2020.4409 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2020.4409</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Luo D, Sun M, et al. No causal association between serum vitamin D levels and diabetes retinopathy: A Mendelian randomization analysis. Nutr Metab Cardiovasc Dis May. 2024;34(5):1295&#x2013;304. https://doi.org/10.1016/j.numecd.2024.01.033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2024.01.033</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong XX, Chen DL, Miao YF, et al. The impact of 25-hydroxyvitamin D and calcium on the risk of age-related macular degeneration: A Mendelian randomization study. Am J Clin Nutr Jul. 2024;2. https://doi.org/10.1016/j.ajcnut.2024.06.018 .</Citation></Reference><Reference><Citation>Fang A, Zhao Y, Yang P, Zhang X, Giovannucci EL. Vitamin D and human health: evidence from Mendelian randomization studies. Eur J Epidemiol May. 2024;39(5):467&#x2013;90. https://doi.org/10.1007/s10654-023-01075-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-023-01075-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P, Peakman TC. The UK biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol Apr. 2008;37(2):234&#x2013;44. https://doi.org/10.1093/ije/dym276 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dym276</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjedi KM, Stuart KV, Chua SYL, et al. The association of physical activity with Glaucoma and related traits in the UK biobank. Ophthalmology Oct. 2023;130(10):1024&#x2013;36. https://doi.org/10.1016/j.ophtha.2023.06.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2023.06.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua SYL, Warwick A, Peto T, et al. Association of ambient air pollution with age-related macular degeneration and retinal thickness in UK biobank. Br J Ophthalmol May. 2022;106(5):705&#x2013;11. https://doi.org/10.1136/bjophthalmol-2020-316218 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-316218</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Schweren LJS, Ter Horst R, et al. Low-grade inflammation as mediator between diet and behavioral disinhibition: A UK biobank study. Brain Behav Immun Nov. 2022;106:100&#x2013;10. https://doi.org/10.1016/j.bbi.2022.07.165 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.07.165</ArticleId></ArticleIdList></Reference><Reference><Citation>Alizargar J, Bai CH, Hsieh NC, Wu SV. Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients. Cardiovasc Diabetol Jan. 2020;15(1):8. https://doi.org/10.1186/s12933-019-0982-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-019-0982-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Haro Gir&#xf3;n S, Monserrat Sanz J, Ortega MA, et al. Prognostic value of malondialdehyde (MDA) in the Temporal progression of chronic spinal cord injury. J Pers Med Apr. 2023;2(4). https://doi.org/10.3390/jpm13040626 .</Citation></Reference><Reference><Citation>Xiu M, Song X, Yang H, Huang X, Wu F, Zhang X. Smoking affects the predictive roles of antioxidant enzymes in the clinical response to Risperidone in schizophrenia: A Large-scale cohort study. Curr Neuropharmacol. 2023;21(10):2151&#x2013;8. https://doi.org/10.2174/1570159x21666230502125800 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159x21666230502125800</ArticleId><ArticleId IdType="pubmed">37132112</ArticleId><ArticleId IdType="pmc">10556368</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton C, Grazioli E, Antinozzi C, et al. Online Home-Based physical activity counteracts changes of Redox-Status biomarkers and fitness profiles during treatment programs in postsurgery female breast Cancer patients. Antioxidants (Basel) May. 2023;22(5). https://doi.org/10.3390/antiox12051138 .</Citation></Reference><Reference><Citation>Kova&#x10d;evi&#x107; M, Mali&#x161; S, Pavlovi&#x107; D, Kova&#x10d;evi&#x107; M, Savi&#x107; Radojevi&#x107; A, Djukanovi&#x107; L. Plasma activity of the antioxidant enzymes in predicting diabetic nephropathy progression. Int Urol Nephrol Jun. 2022;54(6):1365&#x2013;72. https://doi.org/10.1007/s11255-021-03031-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-021-03031-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Lips P, Cashman KD, Lamberg-Allardt C, et al. Current vitamin D status in European and middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European calcified tissue society. Eur J Endocrinol Apr. 2019;180(4):P23&#x2013;54. https://doi.org/10.1530/eje-18-0736 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje-18-0736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, Richards JB. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol Feb. 2022;18(2):96&#x2013;110. https://doi.org/10.1038/s41574-021-00593-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00593-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharibeh N, Razaghi M, Vanstone CA, et al. Effect of vitamin D supplementation on bone mass in infants with 25-Hydroxyvitamin D concentrations less than 50 Nmol/L: A prespecified secondary analysis of a randomized clinical trial. JAMA Pediatr Apr. 2023;1(4):353&#x2013;62. https://doi.org/10.1001/jamapediatrics.2022.5837 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2022.5837</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x142;udowski P, Kos-Kud&#x142;a B, Walczak M, et al. Guidelines for preventing and treating vitamin D deficiency: A 2023 update in Poland. Nutrients Jan. 2023;30(3). https://doi.org/10.3390/nu15030695 .</Citation></Reference><Reference><Citation>Herrmann M, Sullivan DR, Veillard AS, et al. Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care Mar. 2015;38(3):521&#x2013;8. https://doi.org/10.2337/dc14-0180 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-0180</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng T, Lu Q, Wan Z, et al. Association of serum 25-hydroxyvitamin D concentrations with risk of dementia among individuals with type 2 diabetes: A cohort study in the UK biobank. PLoS Med. Jan 2022;19(1):e1003906. https://doi.org/10.1371/journal.pmed.1003906 .</Citation></Reference><Reference><Citation>!!!. INVALID CITATION!!!.</Citation></Reference><Reference><Citation>Chen C, Wei L, He W, et al. Associations of severe liver diseases with cataract using data from UK biobank: a prospective cohort study. EClinicalMedicine Feb. 2024;68:102424. https://doi.org/10.1016/j.eclinm.2024.102424 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.102424</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao H, Cheng J, Pan D, et al. Association of earlier age at menopause with risk of incident dementia, brain structural indices and the potential mediators: a prospective community-based cohort study. EClinicalMedicine Jun. 2023;60:102033. https://doi.org/10.1016/j.eclinm.2023.102033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102033</ArticleId></ArticleIdList></Reference><Reference><Citation>Atalay K, Savur FG, Kirgiz A, Kald&#x131;r&#x131;m HE, Zengi O. Serum levels of thyroid hormone, vitamin D, vitamin B12, folic acid, C-reactive protein, and hemoglobin in pseudoexfoliation and primary open angle Glaucoma. J Fr Ophtalmol Sep. 2019;42(7):730&#x2013;8. https://doi.org/10.1016/j.jfo.2019.01.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfo.2019.01.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y, Yao Q, Ma W, Liu H, Ji J, Li X. Associations of vitamin D deficiency and vitamin D receptor (Cdx-2, Fok I, Bsm I and Taq I) polymorphisms with the risk of primary open-angle glaucoma. BMC Ophthalmol Jul 19. 2016;16:116. https://doi.org/10.1186/s12886-016-0289-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-016-0289-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HT, Kim JM, Kim JH, et al. The relationship between vitamin D and glaucoma: A Kangbuk Samsung health study. Korean J Ophthalmol Dec. 2016;30(6):426&#x2013;33. https://doi.org/10.3341/kjo.2016.30.6.426 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3341/kjo.2016.30.6.426</ArticleId></ArticleIdList></Reference><Reference><Citation>Scragg R. Emerging Evidence of Thresholds for Beneficial Effects from Vitamin D Supplementation. Nutrients. May 3. 2018;10(5) https://doi.org/10.3390/nu10050561</Citation></Reference><Reference><Citation>Ala-Korpela M. The epidemiological quest for the role of vitamin D turned non-linear-and simply made sense. Int J Epidemiol Feb. 2023;8(1):1&#x2013;4. https://doi.org/10.1093/ije/dyac218 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac218</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Guo D, Xu B, et al. Association of serum 25-Hydroxyvitamin D with cardiovascular outcomes and All-Cause mortality in individuals with prediabetes and diabetes: results from the UK biobank prospective cohort study. Diabetes Care May. 2022;1(5):1219&#x2013;29. https://doi.org/10.2337/dc21-2193 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-2193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou A, Selvanayagam JB, Hypp&#xf6;nen E. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J May. 2022;7(18):1731&#x2013;9. https://doi.org/10.1093/eurheartj/ehab809 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima G, Iliffe S, Tanabe M. Vitamin D supplementation as a potential cause of U-shaped associations between vitamin D levels and negative health outcomes: a decision tree analysis for risk of frailty. BMC Geriatr Oct. 2017;16(1):236. https://doi.org/10.1186/s12877-017-0631-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-017-0631-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wall-Gremstrup G, Holt R, Yahyavi SK, et al. High-dose vitamin D(3) supplementation shows no beneficial effects on white blood cell counts, acute phase reactants, or frequency of respiratory infections. Respir Res Jan. 2024;4(1):11. https://doi.org/10.1186/s12931-023-02642-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-023-02642-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson-Hughes B, Harris SS. High-dose vitamin D supplementation: too much of a good thing? Jama May. 2010;12(18):1861&#x2013;2. https://doi.org/10.1001/jama.2010.598 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders KM, Nicholson GC, Ebeling PR. Is high dose vitamin D harmful? Calcif Tissue Int Feb. 2013;92(2):191&#x2013;206. https://doi.org/10.1007/s00223-012-9679-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-012-9679-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders KM, Stuart AL, Williamson EJ et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. Jama. May 12. 2010;303(18):1815-22. https://doi.org/10.1001/jama.2010.594</Citation></Reference><Reference><Citation>Francis RM. The vitamin D paradox. Rheumatology (Oxford) Dec. 2007;46(12):1749&#x2013;50. https://doi.org/10.1093/rheumatology/kem292 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kem292</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanherwegen AS, Gysemans C, Mathieu C. Vitamin D endocrinology on the cross-road between immunity and metabolism. Mol Cell Endocrinol Sep. 2017;15:453:52&#x2013;67. https://doi.org/10.1016/j.mce.2017.04.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2017.04.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao D, Trayhurn P, Bing C. 1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes (Lond) Mar. 2013;37(3):357&#x2013;65. https://doi.org/10.1038/ijo.2012.53 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2012.53</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Baylink DJ, Deb C, et al. 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS ONE. 2013;8(3):e58808. https://doi.org/10.1371/journal.pone.0058808 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058808</ArticleId><ArticleId IdType="pubmed">23516559</ArticleId><ArticleId IdType="pmc">3597563</ArticleId></ArticleIdList></Reference><Reference><Citation>Neve A, Corrado A, Cantatore FP. Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. Clin Exp Med Aug. 2014;14(3):275&#x2013;83. https://doi.org/10.1007/s10238-013-0249-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-013-0249-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract Jul. 2007;77(1):47&#x2013;57. https://doi.org/10.1016/j.diabres.2006.10.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2006.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Barragan M, Good M, Kolls JK. Regulation of Dendritic Cell Function by Vitamin D. Nutrients. Sep 21. 2015;7(9):8127-51. https://doi.org/10.3390/nu7095383</Citation></Reference><Reference><Citation>Abbas MA. Physiological functions of vitamin D in adipose tissue. J Steroid Biochem Mol Biol Jan. 2017;165(Pt B):369&#x2013;81. https://doi.org/10.1016/j.jsbmb.2016.08.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2016.08.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee V, Rekhi E, Hoh Kam J, Jeffery G. Vitamin D rejuvenates aging eyes by reducing inflammation, clearing amyloid beta and improving visual function. Neurobiol Aging Oct. 2012;33(10):2382&#x2013;9. https://doi.org/10.1016/j.neurobiolaging.2011.12.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.12.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle MS, Russo C, Malaguarnera L. Protective role of vitamin D against oxidative stress in diabetic retinopathy. Diabetes Metab Res Rev Nov. 2021;37(8):e3447. https://doi.org/10.1002/dmrr.3447 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3447</ArticleId></ArticleIdList></Reference><Reference><Citation>Serbis A, Giapros V, Tsamis K, Balomenou F, Galli-Tsinopoulou A, Siomou E. Beta cell dysfunction in Youth- and Adult-Onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients. Nutrients May. 2023;7(9). https://doi.org/10.3390/nu15092217 .</Citation></Reference><Reference><Citation>Wolden-Kirk H, Rondas D, Bugliani M, et al. Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse Islets of Langerhans. Endocrinology Mar. 2014;155(3):736&#x2013;47. https://doi.org/10.1210/en.2013-1409 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2013-1409</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroia CM, Ghitea TC, Vr&#xe2;nceanu M, et al. Relationship between vitamin D3 deficiency, metabolic syndrome and VDR, GC, and CYP2R1 gene polymorphisms. Nutrients Apr. 2024;25(9). https://doi.org/10.3390/nu16091272 .</Citation></Reference><Reference><Citation>Aggeletopoulou I, Tsounis EP, Triantos C. Vitamin D and metabolic Dysfunction-Associated steatotic liver disease (MASLD): novel mechanistic insights. Int J Mol Sci Apr. 2024;30(9). https://doi.org/10.3390/ijms25094901 .</Citation></Reference><Reference><Citation>Hoseini Z, Behpour N, Hoseini R. Aerobic training with moderate or high doses of vitamin D improve liver enzymes, LXR&#x3b1; and PGC-1&#x3b1; levels in rats with T2DM. Sci Rep Mar. 2024;17(1):6409. https://doi.org/10.1038/s41598-024-57023-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-57023-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Lontchi-Yimagou E, Kang S, Goyal A, et al. Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: studies in humans and mice. Mol Metab Dec. 2020;42:101095. https://doi.org/10.1016/j.molmet.2020.101095 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2020.101095</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymczak-Pajor I, Drzewoski J, &#x15a;liwi&#x144;ska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci Sep. 2020;11(18). https://doi.org/10.3390/ijms21186644 .</Citation></Reference><Reference><Citation>Guo Z, Ma X, Zhang RX, Yan H. Oxidative stress, epigenetic regulation and pathological processes of lens epithelial cells underlying diabetic cataract. Adv Ophthalmol Pract Res Nov-Dec. 2023;3(4):180&#x2013;6. https://doi.org/10.1016/j.aopr.2023.10.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aopr.2023.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Wang J, Fan Y, Chen S, Wang L, Ma J. Effect of 1,25(OH)(2)D(3) on rat peritoneal mesothelial cells treated with high glucose plus lipopolysaccharide. Cell Immunol. 2011;271(1):173&#x2013;9. https://doi.org/10.1016/j.cellimm.2011.06.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2011.06.017</ArticleId><ArticleId IdType="pubmed">21788014</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieth R, Vitamin. D toxicity, policy, and science. J Bone Min Res Dec. 2007;22(Suppl 2):V64&#x2013;8. https://doi.org/10.1359/jbmr.07s221 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.07s221</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CL, Kirk B, Xiang M, et al. Very low and high levels of vitamin D are associated with shorter leukocyte telomere length in 148,321 UK biobank participants. Nutrients Mar. 2023;19(6). https://doi.org/10.3390/nu15061474 .</Citation></Reference><Reference><Citation>Thompson RB, Reffatto V, Bundy JG, et al. Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye. Proc Natl Acad Sci U S A Feb. 2015;3(5):1565&#x2013;70. https://doi.org/10.1073/pnas.1413347112 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1413347112</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Sun X, Martinez-Wittinghan FJ, Gong X, White TW, Mathias RT. Connections between connexins, calcium, and cataracts in the lens. J Gen Physiol Oct. 2004;124(4):289&#x2013;300. https://doi.org/10.1085/jgp.200409121 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1085/jgp.200409121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaarniranta K, Blasiak J, Liton P, Boulton M, Klionsky DJ, Sinha D. Autophagy in age-related macular degeneration. Autophagy Feb. 2023;19(2):388&#x2013;400. https://doi.org/10.1080/15548627.2022.2069437 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2022.2069437</ArticleId></ArticleIdList></Reference><Reference><Citation>van Schoor NM, Knol DL, Deeg DJ, Peters FP, Heijboer AC, Lips P. Longitudinal changes and seasonal variations in serum 25-hydroxyvitamin D levels in different age groups: results of the longitudinal aging study Amsterdam. Osteoporos Int May. 2014;25(5):1483&#x2013;91. https://doi.org/10.1007/s00198-014-2651-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-014-2651-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu K, Hunter M, Hui J, et al. Longitudinal stability of vitamin D status and its association with bone mineral density in Middle-aged Australians. J Endocr Soc Dec. 2022;15(2):bvac187. https://doi.org/10.1210/jendso/bvac187 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvac187</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol Apr. 2010;15(8):903&#x2013;8. https://doi.org/10.1093/aje/kwq005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq005</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>